Higher Expression of With Lower Expression may be Biomarkers for Risk Stratification of Patients With Cytogenetically Normal Acute Myeloid Leukemia

Higher Expression of With Lower Expression may be Biomarkers for Risk Stratification of Patients With Cytogenetically Normal Acute Myeloid Leukemia

Background: Cytogenetics at diagnosis is the most important prognostic factor for adult acute myeloid leukemia (AML), but nearly 50% of AML patients who exhibit cytogenetically normal AML (CN-AML) do not undergo effective risk stratification. Therefore, the development of potential biomarkers to fur...

Full description

Bibliographic Details
Main Authors: Cunte Chen MD, Zhuowen Chen MD, Chi Leong Chio MD, Ying Zhao MD, Yongsheng Li MM, Zhipeng Liu MM, Zhenyi Jin MD, Xiuli Wu MD, Wei Wei PhD, Qi Zhao PhD, Yangqiu Li MD
Format: Article
Language:English
Published: SAGE Publishing 2021-11-01
Series:Technology in Cancer Research & Treatment
Online Access:https://doi.org/10.1177/15330338211052152

Internet

https://doi.org/10.1177/15330338211052152

Similar Items